Oncology
September is Gynecologic and Ovarian Cancer Awareness Month
Discover GSK's Our Way Forward website, created in partnership with patients and advocacy groups to support those affected by ovarian and endometrial cancer. It offers a space to learn, share, and move forward-whether you're at risk, newly diagnosed, or supporting a loved one.
Investors
We announced our quarter 2 2025 results on Wednesday, July 30th.
Press releases
- Gepotidacin accepted for priority review by the US FDA for the oral treatment of uncomplicated urogenital gonorrhea
- GSK sponsors 2025 National Senior Games as part of Sideline RSV campaign to raise awareness of RSV in older adults
- GSK announces extension of US Food and Drug Administration review period for Blenrep (belantamab mafodotin-blmf) in relapsed/refractory multiple myeloma

GSK Global links
Visit our Global site for additional features